• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR SARS-COV-2 IGG (SCOVG); SARS-COV-2 IMMUNOASSAY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR SARS-COV-2 IGG (SCOVG); SARS-COV-2 IMMUNOASSAY, Back to Search Results
Model Number N/A
Device Problem Failure to Calibrate (2440)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/09/2022
Event Type  malfunction  
Manufacturer Narrative
A customer from outside of the united states observed reproducible calibration failure when using the advia centaur xpt sars-cov-2 igg (scovg) assay.There are no allegations of patient harm, changes in treatment, or diagnostic delays due to the observed calibration failure.Siemens healthcare diagnostics is investigating the observed problem.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).
 
Event Description
The customer reports observation of reproducible calibration failure when using the advia centaur sars-cov-2 igg (scovg) assay.High cv for the high calibrator was observed.There are no known reports of patient intervention or adverse health consequences due to the scovg calibration failure.
 
Manufacturer Narrative
Mdr 1219913-2022-00404 was initially filed on 2022-11-29.Additional information, 2022-12-13: siemens healthcare diagnostics inc.Investigation confirmed that the failed calibrations are due to the standard s01 value in the master curve card (mcc) for the advia centaur systems lots 19529015 and 27236015, being set at 0.1 index.The s01 value should be 0.01 index.The issue is isolated to the advia centaur systems scovg lots 19529015 and 27236015, smns 1120376 and 1120379.Customers were notified of the issue and instructed to discontinue use of the kits.(us: cc 23-01.A.Us was sent to us customers on 2022-12-16 and outside the us: cc 23-01.A.Ous was sent to customers on 2022-12-16 who have received the advia centaur systems sars-cov-2 igg (scovg) lots 19529015 and 27236015).Note: in section h6, the codes for type of investigation, investigation findings and investigation conclusion have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR SARS-COV-2 IGG (SCOVG)
Type of Device
SARS-COV-2 IMMUNOASSAY,
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
east walpole MA 02032
Manufacturer Contact
barry
333 coney street
east walpole, MA 02032
5082985306
MDR Report Key15878390
MDR Text Key304458422
Report Number1219913-2022-00404
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
EUA202670
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/21/2023
Device Model NumberN/A
Device Catalogue Number11207376
Device Lot Number015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/21/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-